Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OrganoClick ABFRA:0CF -18.07%25 3-Year EBITDA Growth Rate is 16.30% as of Mar. 2026, which is 366% above its 10-year median of 3.50. GuruFocus rates FRA:0CF with a GF Score™ of 25/100 and a GF Value™ of €0.13. The stock has 4 warning signs investors should review. Among 1,408 Chemicals companies, OrganoClick AB ranks better than 76.49% on this metric.
During the past 12 months, OrganoClick AB's average EBITDA Per Share Growth Rate was -388.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of OrganoClick AB was 53.00% per year. The lowest was -78.20% per year. And the median was 3.50% per year.
OrganoClick AB (FRA:0CF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
OrganoClick AB 3-Year EBITDA Growth Rate Related Terms
FRA:0CF vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's 3-Year EBITDA Growth Rate falls into.
OrganoClick AB 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 16.30% mean?
OrganoClick AB (FRA:0CF) has a 3-Year EBITDA Growth Rate of 16.30% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for OrganoClick AB and its competitors. This is 366% above median its historical median of 3.50. According to the industry distribution chart, OrganoClick AB ranks #331 out of 1408 companies in the Chemicals industry, placing it in the top 23.5%.
Is OrganoClick AB's 3-Year EBITDA Growth Rate too high?
OrganoClick AB's current 3-Year EBITDA Growth Rate of 16.30% is 366% above median its 10-year median of 3.50. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.85. OrganoClick AB's value of 16.30% is 1817.6% above this industry median. Based on the distribution chart, OrganoClick AB ranks #331 out of 1408 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, OrganoClick AB ranks #331 out of 1408 companies for 3-Year EBITDA Growth Rate. This places OrganoClick AB in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.85. OrganoClick AB's value of 16.30% is 1817.6% above this benchmark. While the company's 10-year median is 3.50 vs. the industry median of 0.85, OrganoClick AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.85, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrganoClick AB's current 3-Year EBITDA Growth Rate of 16.30% is 1817.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for OrganoClick AB and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current 3-Year EBITDA Growth Rate is 16.30%, which is 366% above median its own 10-year median of 3.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current 3-Year EBITDA Growth Rate of 16.30%. The stock's GF Value™ is €0.13, compared to a current price of €0.03 — trading 79.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 16.30%, which is 366% above median its 10-year median of 3.50 and 1817.6% above the Chemicals industry median of 0.85. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current 3-Year EBITDA Growth Rate is 16.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (FRA:0CF) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of €0.03 is trading 79.1% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:0CF:
3-Year EBITDA Growth Rate: 16.30% (366% above median its 10-year median of 3.50)
GF Value™: €0.13 vs. price of €0.03 (79.1% below fair value)
Industry Position: 1817.6% above the Chemicals median (#331 of 1408)
No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for FRA:0CF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0CF has been successfully added to your 
